SUSMED,Inc. (TYO:4263)

Revenue by Product

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Digital Therapeutics Product	200.00M
Digital Therapeutics Product Growth	-50.00%
Digital Therapeutics Platform	142.58M
Digital Therapeutics Platform Growth	9.13%

Revenue by Geography

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Japan	342.58M
Japan Growth	-35.44%